JosephPrimoUbertiMDPhD

PubMed

• Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial.
  Jason G Dehn, Brent Logan, Bronwen E Shaw, Steven Devine, Stefan O Ciurea
  Medrxiv. 2024-09-16
• 1 citations
  Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis.
  Dipenkumar Modi, Seongho Kim, Maya Shatta, Abhinav Deol, Andrew Kin
  Bone Marrow Transplantation. 2024-08-01
• 3 citations
  A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.
  John Magenau, Samantha Jaglowski, Joseph Uberti, Sherif S Farag, Mary Mansour Riwes
  Blood. 2024-01-04

Journal Articles

• Incidence, Risk Factors, and Outcome of Cytomegalovirus Viremia and Gastroenteritis in Patients with Gastrointestinal Graft-Versus-Host Disease  
  Bhutani D, Dyson G, Manasa R, Deol A, Ratanatharathorn V, Ayash L, Abidi M, Lum LG, Al-Kadhimi Z, Uberti JP, Biol Blood Marrow Transplant, 1/1/2015
• Low-dose Antithymocyte Globulin Enhanced the Efficacy of Tacrolimus and Mycophenolate for GVHD Prophylaxis in Recipients of Unrelated SCT  
  Ratanatharathorn V, Deol A, Ayash L, Cronin S, Bhutani D, Lum L, Abidi M, Ventimiglia M, Mellert K, Uberti JP, Bone Marrow Tranpslant, 1/1/2015
• High Incidence of Severe Acute Graft-Versus-Host Disease with Tacrolimus and Mycophenolate Mofetil in a Large Cohort of Related and Unrelated Allogeneic Transplantatio...  
  Al-Kadhimi Z, Gul Z, Chen W, Smith D, Abidi M, Deol A, Ayash L, Lum L, Waller EK, Ratanatharathorn V, Uberti, J, Biol Blood Marrow Transplant, 1/1/2014
• Successful Hematopoietic Stem Cell (HSC) Collection in Patients Who Fail Initial Plerixafor Mobilization for Autologous Stem Cell Transplant (ASCT)  
  Veeraputhiran M, Jain T, Cronin S, Al-Kadhimi Z, Abidi M, Ayash L, Lum L, Ratanatharathorn V, Uberti JP , Deol A, Journal of Clinical Apheresis, 1/1/2014
• Plerixafor and G-CSF for Autologous Stem Cell Mobilization in Patients with NHL, Hodgkin’s Lymphoma and Multiple Myeloma: Results From the Expanded Access Program  
  Shaughnessy P, Uberti J, Devine S, Maziarz RT, Vose J, Micallef I, Jacobsen E, McCarty J, Stiff P, Artz A, Ball ED, Berryman R, Dugan M, Joyce R, Hsu FJ, Johns D, McSw..., Bone Marrow Transplant, 1/1/2013
• G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT  
  Micallef IN, Jacobsen ED, Shaughnessy P, Gandhi PJ, Calandra G, van Rhee F, Uberti J, Bone Marrow Transplantation, 1/1/2013
• CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkins Lymphoma  
  Lum LG, Thakur A, Liu Q, Deol A, Al-Kadhimi Z, Ayash L, Abidi MH, Pray C, Tomaszewski EN, Steele PA, Schalk DL, Yano H, Mitchell A, Dufresne M, Uberti JP, Ratanatharat..., Biol Blood Marrow Transplant, 1/1/2013
• Long-Term Follow Up on Patients Proceeding to Transplant Using Plerixafor Mobilized Stem Cells and Incidence of Secondary Myelodysplastic Syndrome/AML  
  Deol A, Abrams J, Masood A, Al-Kadhimi Z, Abidi MH, Ayash L, Lum LG, Ratanatharathorn V, Uberti JP, Bone Marrow Transplant, 1/1/2013
• Evaluating the Effects of Lenalidomide Induction Therapy on Peripheral Stem Cell Collection in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma  
  Bhutani D, Zonder J, Valent J, Tageja N, Ayash L, Deol A, Al-Kadhimi Z, Abrams J, Lum L, Ratanatharathorn V, Uberti J, Abidi MH, Support Cancer Care, 1/1/2013
• Extensive Toxic Epidermal Necrolysis versus Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem-Cell Transplantation: Challenges in Diagnosis and Manag...  
  Macedo FI, Faris J, Lum LG, White MT, Gabali A, Uberti JP, Ratanatharathorn V, Journal of Burn Care and Research, 1/1/2013
• Aprepitant for Prevention of Nausea and Vomiting Secondary to High-Dose Cyclophosphamide Administered to Patients Undergoing Autologous Peripheral Blood Stem Cells Mob...  
  Abidi MH, Tageja N, Ayash L, Abrams J, Ratanatharathorn V, Al-Kadhimi Z, Lum L, Cronin S, Ventimiglia M, Uberti J, Support Care Cancer, 1/1/2012
• Targeting Cytomegalovirus-Infected Cells Using T Cells Armed with Anti-CD3 x Anti-CMV Bispecific Antibody  
  Lum LG, Ramesh M, Thakur A, Mitra S, Deol A, Uberti JP, Pellett PE, Biol Blood Marrow Transplant, 1/1/2012
• Large Pericardial Effusions as a Complication in Adult Patients Undergoing Stem Cell Transplantation  
  Norkin M, Ratanatharathorn V, Ayash L, Abidi M, Al-Kadhimi Z, Lum L, Uberti JP, Bone Marrow Transplant, 1/1/2011
• Pathophysiology, Prevention and Treatment of Acute Graft-vs-Host Disease Transplant Research and Risk Management  
  Deol A, Ratanatharathorn V, Uberti JP, Transplant Research and Risk Management, 1/1/2011
• Tacrolimus Disposition in the Ascitic Fluid of a Bone Marrow Transplant Patient  
  Ibrahim R, Abidi M, Al-Kadhimi Z, Uberti JP, Edwards DJ, The Annals of Pharmacotherapy, 1/1/2010
• The Role of B Cell Depleting Therapy in GVHD after Allogeneic Hematopoietic Cell Transplantation  
  Alousi A, Uberti JP, Ratanatharathorn V, Leukemia and Lymphoma, 1/1/2010
• Repeated Course of Rituximab for Treatment of Nephrotic Syndrome in Patients with Chronic-Graft-versus-Host Disease  
  Mellon-Reppen S, Ratanatharathorn V, Cronin S, Uberti JP, Bone Marrow Transplant, 1/1/2010
• Long Term Follow-up of Allogeneic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes Using Busulfan, Cytosine arabinoside and Cyclophosphamide (BAC)  
  Atallah E, Abrams J, Ayash L, Bentley G, Abidi M, Ratanatharathorn V, Uberti JP, Am J Hematol, 1/1/2010
• Clinical Applications of Rituximab in Allogeneic Stem Cell Transplantation: Anti-Tumor and Immunomodulatory Effects  
  Ratanatharathorn V, Pavletic S, Uberti JP, Cancer Treatment Rev, 1/1/2009
• Prior Rituximab Correlates With Less Acute Graft-versus-Host Disease and Better Survival  
  Ratanatharathorn V, Logan B, Wang D, Horowitz M, Uberti J, Ringden O, Gale RP, Khoury H, Arora M, Spellman S, Cutler C, Antin J, Bornhaeuser M, Hale G, Verdonck L, Cai..., British Journal of Haematology, 1/1/2009
• Adult Human Mesenchymal Stem Cells Added to Corticosteroid Therapy Improves Outcomes of Acute Graft versus Host Disease  
  Kebriaei P, Isola L, Bahceci E, Holland K, Rowley S, McGuirk J, Devetten M, Jansen J, Herzig R, Schuster M, Monroy R, Uberti JP, Biol Blood Marrow Transplantation, 1/1/2009
• Endpoints for Clinical Trials Testing Treatment of Acute Graft versus Host Disease: A Consensus Document  
  Martin P, Bachier C, Klingeman HG, McCarthy P, Szabolcs P, Uberti JP, Schuster M, Weisdorf D, Chao N, Kebriaei P, Shpall E, MacMillan M, Soiffer R, Biol Blood Marrow Transplantation, 1/1/2009
• Nonabsorbable Corticosteroids Use in the Treatment of Gastrointestinal Graft-versus-Host Disease  
  Ibrahim RB, Abidi, MH, Cronin SM, Lum LG, Al-Kadhimi Z, Ratanatharathorn V, Uberti JP, Biol Blood Marrow Transplantation, 1/1/2009
• Unrelated Donor Bone Marrow Transplantation Using a Chemotherapy-Only Preparative Regimen (BAC) for Adults with High-Risk Acute Myelogenous Leukemia  
  Ayash L, Ratanatharathorn, V, Reynolds C, Braun T, Silver S, Uberti J, American Journal of Hematology, 1/1/2007
• Nephrotic Syndrome Associated with Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation  
  Reddy, P., Johnson, K., Uberti, J.P., Reynolds, C., Silver, S., Ayash, L., Braun, T.M., Ratanatharathorn, V, Bone Marrow Transplantation, 1/1/2006
• Join now to see all

Books/Book Chapters

• Hematology for the Medical Student 
  Chapter: Bone Marrow Transplantation 
  Uberti J, Silver S, Ferrara JLMLippincott Williams and Wilkins2003

Abstracts/Posters

• Maintenance Therapy after Second Autologous Stem Cell Transplant in Multiple Myeloma Improves Overall Survival
  Joseph P. Uberti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Absolute Lymphocyte Count (ALC) Less Than 100 Predicts Adverse Transplant Outcomes with Rabbit Thymoglobulin in Patients Undergoing Matched Unrelated Allogeneic Hemato...
  Joseph P. Uberti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Use of Thymoglobulin with Lower Dose of Busulfan Results in Less Acute Gvhd Following Unrelated Donor Allogeneic Stem Cell Transplantation for AML without Affecting Re...
  Joseph P. Uberti, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Outcomes in Patients on Hemodialysis Who Undergo High Dose therapy Followed by Autologous Peripheral Blood Stem Cell Transplant for Multiple Myeloma in the Era of Nove...
  Ye JC, Nandagopal L, Ventimiglia M, Abidi MH, Ayash L, Lum LG, Uberti JP, Ratanatharathorn V, Zonder J, Bhutani D, Deol A, Blood, 1/1/2014
• Outcomes of Second Autologous Peripheral Blood Stem Cell Transplant in Multiple Myeloma patients with Renal Dysfunction
  Nandagopal L, Ye JC, Manasa R, Abidi MH, Ayash L, Lum LG, Uberti JP, Ratanatharathorn V, Zonder J, Bhutani D, Deol A, Blood, 1/1/2014
• Influence of Race on Outcomes in Multiple Myeloma Patients with Renal Dysfunction Undergoing High Dose Therapy Followed by Autologous Stem Cell Transplant
  Nandagopal L, Ye JC, Ventimiglia M, Abidi MH, Ayash L, Zonder J, Lum LG, Uberti JP, Ratanatharatorn V, Bhutani D, Deol A, Blood, 1/1/2014
• Low Incidence of Late NRM and Severe CGVHD in a Phade II Trail of Theymoglobulin, Tacrolimus and Sirolimus for GVHD Prevention
  Al-Kadhimi, Z., Gul, Z., Chen, W., Smith, D., Mitchell, A., Abidi, M., Ayash, L., Lum, L.G., Deol, A., Ratanatharathorn, V., Uberti, J., 40th EBMT Congress, Milan, Italy, 1/1/2014
• Antithymocyte Globulin (Rabbit) Enhanced The Efficacy Of Tacrolimus and Mycophenolate For Graft-Versus-Host Disease Prophylaxis In Recipients Of Unrelated Stem Cell Tr...
  Ratanatharathorn V, Deol A, Ayash L, Bhutani D, Lum LG, Al-Kadhimi Z, Abidi MH, Ventimiglia M, Mellert K, Uberti JP, Blood, 1/1/2013
• Induction Of Anti-Myeloma Cellular and Humoral Immunity By Pre-Targeting Clonogenic Myeloma Cells Prior To Stem Cell Transplant With T Cells Armed With Anti-CD3 x Anti...
  Thakur A, Deol A, Ayash L, Tomaszewski EN, Yano H, Schalk DL, Kondadasula SV, Steele PA, Zonder JA, Uberti JP, Ratanatharathorn V, Abidi MH, Blood, 1/1/2013
• Low Incidence Of Severe Cgvhd and Late NRM In a Phase II Trial Of Thymoglobulin, Tacrolimus and Sirolimus For Gvhd Prevention
  Eghtedar A, Gul Z, Chen W, Smith D, Deol A, Abidi MH, Lum LG, Bhutani D, Ayash L, Ratanatharathorn V, Uberti JP, Blood, 1/1/2013
• Incidence, Risk Factors and Outcome Of Cytomegalovirus (CMV) Viremia and CMV Gastroenteritis In Patients With Gastrointestinal Graft Versus Host Disease (GI GVHD)
  Dyson G, Manasa R, Ratanatharathorn V, Deol A, Abidi MH, Al-Kadhimi Z, Ayash L, Lum LG, Uberti JP, Blood, 1/1/2013
• Melphalan 180mg/m2 Can Be Safely Administered as Conditioning Regimen Prior to an Autologous Stem Cell Transplantation in Multiple Myeloma Patients with Creatinine Cle...
  Abidi M, Agarwal R, Tageja N, Ayash L, Ventimiglia M, Deol A, Al-Kadhimi Z, Lum L, Ratanatharathorn V, Abrams J, Uberti J, BMT Tandem Meetings, San Diego, CA, 1/1/2012
• Stem Cell Mobilization Failures Salvaged with Plerixafor – Long Term Follow Up of Engraftment and Outcomes
  A Deol, J Abrams, A Masood, Z Al-Kadhimi, M Abidi, L Ayash, V Ratanatharathorn, L Lum, Uberti J, BMT Tandem Meetings, San Diego, CA, 1/1/2012
• Is Liver Biopsy Necessary in the Management of Allogeneic Stem Cell Transplant Recipients with Graft-versus-Host-Disease?
  Ye, JC, Hukku S, Bentley G, Lebeis T, Ratanatharathorn V, Lum LG, Ayash L, Abidi M, Al-Kadhimi Z, Deol A, Mellert K, Uberti JP, BMT Tandem Meetings, San Diego, CA, 1/1/2012
• T-Cells targeted with anti-CD3 x anti-HER2 bispecific antibody for treatment of women with stage IV breast cancer (phase I): Clinical and immune function results
  L.G. Lum, R. Rathore, Z. Al-Kadhimi, P. Davol, A. Thakur, C. Pray, Q. Liu, E. Tomaszewski, F. Cummings, P. Steele, J. Wedge, N. Kouttab, A. Maizel, W. Colaiace, R. Joy..., ASCO Annual Meeting, McCormick Place, Chicago, IL, 1/1/2011
• A Phase I Trial to Evaluate Safety of T Cells Armed with Bispecific Antibody Targeting Multiple Myeloma (MM) Cancer Stem Cells (CSC) to Boose Post Autologous Stem Cell...
  Abidi M, Al-Khadimi Z, Thakur A, Tomaszewski K, Ratanatharathorn V, Uberti J, Ayash L, Deol A, Steele P, Myers K, Schalk D, Dominiak K, Kondadasula S, Zonder J, Lum L, Haematologica, 13th International Myeloma Workshop, Paris, France, 1/1/2011
• Comparison of Clinical Outcomes and Day 30 Lymphocyte Recovery Between Two aGVHD Prophylaxis Regimens in Matched Unrelated Hematopoietic Stem Cell Transplant (MUD) Pat...
  Gul Z, Abdul-Hussein M, Ditah I, Uberti JP, Abidi M, Ayash L, Lum LG, Ratanatharathorn V, Al-Kadhimi Z, American Society of Hematology, 1/1/2010
• Cytoprotective Palifermin Allowed Melphalan Dose Escalation to 280mg/2 for Multiple Myeloma Patients with Normal Renal Function Receiving Autologous Stem Cell Transpla...
  Abidi M, Tageja N, Lum LG, Abrams J, Al-Kadhimi Z, Ayash L, Cronin S, Ventimiglia M, Deol A, Ratanatharathorn V, Uberti JP, American Society of Hematology, 1/1/2010
• A Phase I Study of Bortezomib During Maintenance Phase After High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma
  Abidi M, Gul Z, Lum LG, Abrams J, Cronin S, Ventimiglia M, Deol A, Ayash L, Al-Kadhimi Z, Ratanatharathorn V, Uberti JP, American Society of Hematology, 1/1/2010
• Phase I Dose Escalation of Activated T Cells (ATC) Armed with Anti-CD3 x Anti-CD20 Bispecific Antibody (CD20Bi) After Stem Cell Transplant (SCT) in Non-Hodgkin’s Lymph...
  Lum LG, Ratanatharathorn V, Thakur A, Al-Kadhimi Z, Skuba C, Paul E, Steele P, Ayash L, Abidi M, Uberti JP, American Society of Hematology, 1/1/2010
• Phase I Clinical Trial Involving Infusions of Activated T Cells Armed with Anti-CD3 x Anti-Her2/neu bispecific antibody in women with metastatic breast cancer: Clinica...
  Lum LG, Thakur A, Rathore R, Al-Kadhimi ZS, Uberti JP, Ratanatharathorn V, Breast Cancer Symposium, 1/1/2010
• Pre-Transplant Priming with T-cells Armed with Anti-CD3 x anti-Her2/neu Bispecific Antibody (Her2Bi) and Boosting after PBSCT with Activated T-cells (ATC) for Stave IV...
  Thakur A, Rathore R, Al-Kadhimi Z, Uberti JP, Ratanatharathorn V, Lum LG, ASCO Meeting, 1/1/2010
• Enhanced Immune Reconstitution Despite In Vivo Lympho-Depletion As Part of Acute Graft vs Host Disease aGVHD Prophylaxis in Unrelated Hematopoietic Stem Cell Transplan...
  Gul Z, Abdul-Hussein, Abidi M, Ayash L, Lum L, Chen W, Uberti J, Ratanatharathorn V, Al-Kadhimi Z, BMT Tandem Meetings, 1/1/2010
• Reviewing the Statue of Backup Hematopoietic Stem Cells (HSC) Banking for Multiple Myeloma (MM) Patients Who Are Eligible for Autologous Hematopoietic Stem Cells Trans...
  Abidi MH, Woldie IL, Goveas R, Ratanatharathorn V, Al-Kadhimi Z, Abrams J, Ayash L, Lum L, Uberti J, BMT Tandem Meetings, 1/1/2010
• Primed and Boosted Anti-Breast Cancer Tumor Immunity after Autologous Peripheral Blood Stem Cell Transplant (PBSCT): In Vivo Priming With T Cells Armed with Anti-CD3 X...
  Lum, L.G., Thakur, A., Al-Kadhimi, Z., Abidi, M., Ayash, L., Cummings, F., Rathore, R., Uberti, J.P., and Ratanatharathorn, V., ASBMT Tandem Meetings, 1/1/2010
• Join now to see all

Lectures

• Primer on Stem Cell Transplantation 
  Wayne State University - 1/1/2010
• The Treatment of AML 
  William Beaumont Hospital, Royal Oak, MI - 1/1/2009
• Bone Marrow Transplant – An Overview 
  Wayne State University, Detroit, MI - 1/1/2009
• Alternative Donor Transplants 
  Munson Medical Center - 1/1/2008
• Updates in Stem Cell Transplantation 
  Munson Medical Center - 1/1/2008
• Stem Cell Transplantation 
  Beaumont Hospital, 2007; St. Joseph Mercy Oakland, 2007 - 1/1/2007
• Bone Marrow Transplant on Acute Myeloid Leukemia 
  1/1/2007
• Allogeneic Stem Cell Transplantation 
  Wayne State University School of Medicine, Department of Internal Medicine - 1/1/2006
• Phase I/II Trial on the Use of Etanercept (Enbrel) and Solumedrol as Primary Treatment for Acute Graft-vs-Host Disease (aGVHD). 
  San Diego, California - 1/1/2003
• Genetic Basis of Cancer-Pathways to Cure 
  Wayne State University - 1/25/2014
• Pathways for Academic Careers in Hematology Oncology 
  Wayne State University - 1/4./2013
• Hematopoietic Stem Cell Transplantation 
  Wayne State University, Detroit, MI - 1/5./2006
• Join now to see all

Other

• The role of adenosine and deoxyadenosine on the development of immunodeficiency disease 
  Uberti J, Ph.D. Dissertation
  Department of Biochemistry, Wayne State University School of Medicine, Detroit, MI - 1/1/1979
• Early Referrals and Improvements in Stem Cell Transplants 
  Uberti J, Webinar, Interlink Health Services, Inc
  1/27/2011